Search

Your search keyword '"Martinelli, Giovanni"' showing total 5,057 results
Start Over Author "Martinelli, Giovanni"
5,057 results on '"Martinelli, Giovanni"'

303. A Phase 1b/2 Study of the CD123-Targeting Antibody-Drug Conjugate IMGN632 As Monotherapy or in Combination with Venetoclax and Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia

Author

Daver, Naval, primary, Aribi, Ahmed, additional, Montesinos, Pau, additional, Roboz, Gail J., additional, Wang, Eunice S., additional, Walter, Roland B., additional, Jeyakumar, Deepa, additional, DeAngelo, Daniel J., additional, Erba, Harry P., additional, Advani, Anjali, additional, Burke, Patrick W., additional, Martinelli, Giovanni, additional, Gastaud, Lauris, additional, Thomas, Xavier, additional, Altman, Jessica K., additional, Mendez, Lourdes M., additional, de la Fuente, Adolfo, additional, Todisco, Elisabetta, additional, Gaidano, Gianluca, additional, Curti, Antonio, additional, Boissel, Nicolas, additional, Recher, Christian, additional, Schliemann, Christoph, additional, Sloss, Callum M, additional, Wang, Jiuzhou, additional, Malcolm, Kara E, additional, Zweidler-McKay, Patrick A, additional, and Sweet, Kendra, additional

Published
2021
Full Text
View/download PDF

305. Impact of Comorbidities on Prognosis of Elderly Patients with Acute Myeloid Leukemia Who Receive Hypomethylating Agents

Author

Marconi, Giovanni, primary, Candoni, Anna, additional, di Nicola, Roberta, additional, Sartor, Chiara, additional, Parisi, Sarah, additional, Abbenante, Mariachiara, additional, Nanni, Jacopo, additional, Cristiano, Gianluca, additional, Lazzarotto, Davide, additional, Giannini, Maria Benedetta, additional, Baldazzi, Carmen, additional, Fontana, Maria Chiara, additional, Bandini, Lorenza, additional, Ottaviani, Emanuela, additional, Testoni, Nicoletta, additional, Di Giovanni Bezzi, Chiara, additional, Abd-alatif, Rania, additional, Fanin, Renato, additional, Martinelli, Giovanni, additional, Paolini, Stefania, additional, Cavo, Michele, additional, Papayannidis, Cristina, additional, and Curti, Antonio, additional

Published
2021
Full Text
View/download PDF

307. INO-CD22: A Multi-Center, Real-Life Study on Inotuzumab-Ozogamicin Safety and Effectiveness in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

Author

Papayannidis, Cristina, primary, Zappasodi, Patrizia, additional, Fracchiolla, Nicola S, additional, Di Raimondo, Francesco, additional, Mattei, Daniele Giovanni, additional, Lanza, Francesco, additional, Mauro, Endri, additional, Del Principe, Maria Ilaria, additional, Borlenghi, Erika, additional, Fumagalli, Monica, additional, Todisco, Elisabetta, additional, Sica, Simona, additional, Di Renzo, Nicola, additional, De Fabritiis, Paolo, additional, Corradini, Paolo, additional, Vallisa, Daniele, additional, Petruzziello, Fara, additional, Luppi, Mario, additional, Pane, Fabrizio, additional, Ferrara, Felicetto, additional, Passamonti, Francesco, additional, Mulè, Antonino, additional, Zingaretti, Chiara, additional, Marconi, Giovanni, additional, Valli, Irene, additional, Petracci, Elisabetta, additional, Clemente, Alberto, additional, Saglio, Giuseppe Nicola, additional, Ciceri, Fabio, additional, and Martinelli, Giovanni, additional

Published
2021
Full Text
View/download PDF

308. Dissecting the Adaptive Response to Arginine Deprivation in Hodgkin Lymphoma

Author

Puglisi, Fabrizio, primary, Padella, Antonella, additional, Parrinello, Nunziatina Laura, additional, Scandura, Grazia, additional, Cambria, Daniela, additional, La Spina, Enrico, additional, Barbato, Alessandro, additional, Giallongo, Cesarina, additional, Tibullo, Daniele, additional, Palumbo, Giuseppe A., additional, Cerchione, Claudio, additional, Martinelli, Giovanni, additional, Simonetti, Giorgia, additional, Di Raimondo, Francesco, additional, and Romano, Alessandra, additional

Published
2021
Full Text
View/download PDF

310. Results of the 6-Year Follow-up of the Gimema AML1310 Trial: A Risk-Adapted, MRD-Directed Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia

Author

Venditti, Adriano, primary, Piciocchi, Alfonso, additional, Palmieri, Raffaele, additional, Arena, Valentina, additional, Candoni, Anna, additional, Calafiore, Valeria, additional, Melillo, Lorella MA, additional, Cairoli, Roberto, additional, De Fabritiis, Paolo, additional, Storti, Gabriella, additional, Salutari, Prassede, additional, Lanza, Francesco, additional, Martinelli, Giovanni, additional, Luppi, Mario, additional, Capria, Saveria, additional, Maurillo, Luca, additional, Del Principe, Maria Ilaria, additional, Paterno, Giovangiacinto, additional, Buzzatti, Elisa, additional, Voso, Maria Teresa, additional, Ottone, Tiziana, additional, irno Consalvo, Maria, additional, Fazi, Paola, additional, Vignetti, Marco, additional, Arcese, William, additional, Amadori, Sergio, additional, and Buccisano, Francesco, additional

Published
2021
Full Text
View/download PDF

311. IDH1/2 Mutations Are Maintained in a Subset of Patients with Acute Myeloid Leukemia in Complete Remission and Do Not Correlate with Residual Disease

Author

Marconi, Giovanni, primary, Bandini, Lorenza, additional, Patuelli, Agnese, additional, Sartor, Chiara, additional, Parisi, Sarah, additional, Nanni, Jacopo, additional, Cristiano, Gianluca, additional, Zannoni, Letizia, additional, Simonetti, Giorgia, additional, Bochicchio, Maria Teresa, additional, Ottaviani, Emanuela, additional, Martinelli, Giovanni, additional, Paolini, Stefania, additional, Papayannidis, Cristina, additional, Cavo, Michele, additional, and Curti, Antonio, additional

Published
2021
Full Text
View/download PDF

312. A Study of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate, for Patients with Frontline and Relapsed/Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Author

Pemmaraju, Naveen, primary, Marconi, Giovanni, additional, Todisco, Elisabetta, additional, Montesinos, Pau, additional, Lane, Andrew A., additional, Sweet, Kendra, additional, Wang, Eunice S., additional, Deconinck, Eric, additional, Rizzieri, David A, additional, Walter, Roland B., additional, Aribi, Ahmed, additional, Lebon, Delphine, additional, Levy, Moshe Y., additional, Mazzarella, Luca, additional, Martinelli, Giovanni, additional, Gigli, Federica, additional, Erba, Harry P., additional, Acuña-Cruz, Evelyn, additional, Konopleva, Marina, additional, Kantarjian, Hagop, additional, Sloss, Callum M, additional, Wang, Jiuzhou, additional, Malcolm, Kara E, additional, Zweidler-McKay, Patrick A, additional, DeAngelo, Daniel J., additional, and Daver, Naval, additional

Published
2021
Full Text
View/download PDF

314. Experience with IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Frontline Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Author

Pemmaraju, Naveen, primary, Martinelli, Giovanni, additional, Todisco, Elisabetta, additional, Lane, Andrew A., additional, Acuña-Cruz, Evelyn, additional, Deconinck, Eric, additional, Wang, Eunice S., additional, Sweet, Kendra, additional, Rizzieri, David A, additional, Marconi, Giovanni, additional, Mazzarella, Luca, additional, DeAngelo, Daniel J., additional, Montesinos, Pau, additional, Gigli, Federica, additional, Erba, Harry P., additional, Konopleva, Marina, additional, Kantarjian, Hagop, additional, Walter, Roland B., additional, Aribi, Ahmed, additional, Lebon, Delphine, additional, Levy, Moshe Y., additional, Sloss, Callum M, additional, Malcolm, Kara E, additional, Zweidler-McKay, Patrick A, additional, and Daver, Naval, additional

Published
2021
Full Text
View/download PDF

316. Safety and Efficacy from a Phase 1b/2 Study of IMGN632 in Combination with Azacitidine and Venetoclax for Patients with CD123-Positive Acute Myeloid Leukemia

Author

Daver, Naval, primary, Aribi, Ahmed, additional, Montesinos, Pau, additional, Roboz, Gail J., additional, Wang, Eunice S., additional, Walter, Roland B., additional, Jeyakumar, Deepa, additional, DeAngelo, Daniel J., additional, Erba, Harry P., additional, Advani, Anjali, additional, Burke, Patrick W., additional, Martinelli, Giovanni, additional, Gastaud, Lauris, additional, Thomas, Xavier, additional, Altman, Jessica K., additional, Mendez, Lourdes M., additional, de la Fuente, Adolfo, additional, Todisco, Elisabetta, additional, Gaidano, Gianluca, additional, Curti, Antonio, additional, Boissel, Nicolas, additional, Recher, Christian, additional, Schliemann, Christoph, additional, Konopleva, Marina, additional, Sallman, David A., additional, Torres, Laura, additional, Marcucci, Guido, additional, Kantarjian, Hagop, additional, Sloss, Callum M, additional, Malcolm, Kara E, additional, Zweidler-McKay, Patrick A, additional, and Sweet, Kendra, additional

Published
2021
Full Text
View/download PDF

319. 126. Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection and Vaccination

Author

Snyder, Thomas M, primary, Gittelman, Rachel M, additional, Klinger, Mark, additional, May, Damon H, additional, Osborne, Edward J, additional, Taniguchi, Ruth, additional, Jabran Zahid, H, additional, Elyanow, Rebecca, additional, Dalai, Sudeb C, additional, Kaplan, Ian M, additional, Dines, Jennifer N, additional, Noakes, Matthew T, additional, Pandya, Ravi, additional, Baldo, Lance, additional, Semprini, Simona, additional, Cerchione, Claudio, additional, Nicolini, Fabio, additional, Mazza, Massimiliano, additional, Delmonte, Ottavia M, additional, Dobbs, Kerry, additional, Laguna-Goya, Rocio, additional, Carreño-Tarragona, Gonazalo, additional, Barrio, Santiago, additional, Imberti, Luisa, additional, Sottini, Alessandra, additional, Quiros-Roldan, Eugenia, additional, Rossi, Camillo, additional, Biondi, Andrea, additional, Bettini, Laura Rachele, additional, D’Angio, Mariella, additional, Bonfanti, Paolo, additional, Tompkins, Miranda F, additional, Alba, Camille, additional, Dalgard, Clifton, additional, Sambri, Vittorio, additional, Martinelli, Giovanni, additional, Goldman, Jason D, additional, Heath, James R, additional, Su, Helen C, additional, Notarangelo, Luigi D, additional, Paz-Artal, Estela, additional, Martinez-Lopez, Joaquin, additional, Carlson, Jonathan M, additional, and Robins, Harlan S, additional

Published
2021
Full Text
View/download PDF

320. Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomes

Author

Pallotti, Maria Caterina, primary, Rossi, Romina, additional, Scarpi, Emanuela, additional, Dall’Agata, Monia, additional, Ricci, Marianna, additional, Ceccolini, Michela, additional, Ronconi, Sonia, additional, Valenti, Vanessa, additional, Maltoni, Marco, additional, Martinelli, Giovanni, additional, and Cerchione, Claudio, additional

Published
2021
Full Text
View/download PDF

321. Droplet Digital PCR for BCR–ABL1 Monitoring in Diagnostic Routine: Ready to Start?

Author

Bochicchio, Maria Teresa, primary, Petiti, Jessica, additional, Berchialla, Paola, additional, Izzo, Barbara, additional, Giugliano, Emilia, additional, Ottaviani, Emanuela, additional, Errichiello, Santa, additional, Rege-Cambrin, Giovanna, additional, Venturi, Claudia, additional, Luciano, Luigiana, additional, Daraio, Filomena, additional, Calistri, Daniele, additional, Rosti, Gianantonio, additional, Saglio, Giuseppe, additional, Martinelli, Giovanni, additional, Pane, Fabrizio, additional, Cilloni, Daniela, additional, Gottardi, Enrico M., additional, and Fava, Carmen, additional

Published
2021
Full Text
View/download PDF

324. Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia

Author

Gugliotta, Gabriele, Castagnetti, Fausto, Breccia, Massimo, Gozzini, Antonella, Usala, Emilio, Carella, Angelo M., Rege-Cambrin, Giovanna, Martino, Bruno, Abruzzese, Elisabetta, Albano, Francesco, Stagno, Fabio, Luciano, Luigia, DʼAdda, Mariella, Bocchia, Monica, Cavazzini, Francesco, Tiribelli, Mario, Lunghi, Monia, Pia Falcone, Antonietta, Musolino, Caterina, Levato, Luciano, Venturi, Claudia, Soverini, Simona, Cavo, Michele, Alimena, Giuliana, Pane, Fabrizio, Martinelli, Giovanni, Saglio, Giuseppe, Rosti, Gianantonio, and Baccarani, Michele

Published
2016
Full Text
View/download PDF

327. Notes for a History of Gas Geochemistry.

Author

Zheng, Guodong, Martinelli, Giovanni, Wang, Yanxin, Li, Shun, and Ma, Xiangxian

Subjects
*SCIENTIFIC Revolution, *SEVENTEENTH century, *NATIVE Americans, *EIGHTEENTH century, *GASES, *GEOCHEMISTRY, *GEOPHYSICS
Abstract

During ancient times, human interest in naturally-occurring gases was religious, while it was scientific in the historical age and industrial in modern times. Gases were also utilized for practical purposes and more than 3 000 years before present day, Chinese populations made use of methane for salt extraction while in the 17th century it was observed that native Americans ignited methane seepages. The development of human thinking on gases followed the fundamental steps that characterized the natural sciences during the 18th century scientific revolution that was based on significant improvements in analytical methods. These improvements are still ongoing while present-day scientific publications evidence the spread of the field of interest and more cooperation with geophysical sciences to solve common interest problems. The existence of proper meetings and dedicated scientific journals confirms that gas geochemistry has ended this pioneering phase to enter a more mature condition. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

328. Fall predictors in hospitalized patients living with cancer: a case–control study.

Author

Zeneli, Anita, Montalti, Sandra, Masciangelo, Itria, Manieri, Gloria, Golinucci, Monica, Nanni, Oriana, Montella, Maria Teresa, Martinelli, Giovanni, and Petracci, Elisabetta

Abstract

Purpose: To identify fall predictors and develop an assessment tool to be used for screening hospitalized cancer patients at risk for fall. Methods: A retrospective case–control study was conducted in 2018 at a cancer center in Northern Italy. The study participants were 448 adult cancer patients admitted to the oncology ward from 2009 to 2013. The case group consisted of 112 patients presenting at least one fall, while controls were randomly chosen by matching each case for age, sex, and admission period with three patients who did not fall. Data for the fall predictors were extracted from the electronic medical records. Conditional logistic regression was used to evaluate the association between patient's characteristics and fall risk. Results: The overall prevalence of patients having at least one candidate fall predictor was high (98%). Seven of the studied variables showed an independent association with fall risk at multivariate analysis. These were tumor site, the presence of neurologic diseases, gait imbalance disorders, fatigue, and the assumption of certain medications such as diuretics, hypnotics, and opioids (odds ratios and 95% confidence intervals in brackets were 3.78 (1.78–8.13), 2.26 (1.08–4.77), 4.22 (1.87–9.52), 2.76 (1.45–5.26), 2.66 (1.52–4.66), 2.41 (1.20–4.85), and 3.03 (1.68–5.45), respectively). Conclusions: In this study, we identified falling risk factors in an Italian population of hospitalized cancer patients and developed a new risk assessment tool. An external validation is necessary before implementing our screening tool in clinical practice. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

329. List of Contributors

Author

Belcher, Claire M., primary, Cancellieri, Dominique, additional, Cremonini, Stefano, additional, Filkov, Alexander, additional, Gladky, Denis, additional, Hadden, Rory M., additional, Hernández-Juárez, Norma Lucina, additional, Leroy-Cancellieri, Valerie, additional, Lozano-Santacruz, Rufino, additional, Martinelli, Giovanni, additional, Prat-Guitart, Nuria, additional, Rein, Guillermo, additional, Rich, Fredrick J., additional, Rivero-Navarrete, Axel, additional, Roy, Priyadarsi D., additional, Samonati, Eleonora, additional, Sankar, Gowrappan Muthu, additional, Simeoni, Albert, additional, Stracher, Glenn B., additional, Yearsley, Jonathan M., additional, and Sánchez-Zavala, José Luis, additional

Published
2015
Full Text
View/download PDF

330. A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy

Author

Bassi, Simona, Rabascio, Cristina, Nassi, Luca, Steffanoni, Sara, Babic, Aleksandra, Bertazzoni, Paola, Gigli, Federica, Antoniotti, Pierluigi, Orlando, Laura, Sammassimo, Simona, Quarna, Jessica, Negri, Mara, and Martinelli, Giovanni

Published
2010
Full Text
View/download PDF

331. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

Author

Lo-Coco, Francesco, Avvisati, Giuseppe, Vignetti, Marco, Breccia, Massimo, Gallo, Eugenio, Rambaldi, Alessandro, Paoloni, Francesca, Fioritoni, Giuseppe, Ferrara, Felicetto, Specchia, Giorgina, Cimino, Giuseppe, Diverio, Daniela, Borlenghi, Erika, Martinelli, Giovanni, Di Raimondo, Francesco, Di Bona, Eros, Fazi, Paola, Peta, Antonio, Bosi, Alberto, Carella, Angelo M., Fabbiano, Francesco, Pogliani, Enrico M., Petti, Maria C., Amadori, Sergio, and Mandelli, Franco

Published
2010
Full Text
View/download PDF

334. Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial

Author

Perl, Alexander E., Larson, Richard A, Podoltsev, Nikolai A., Strickland, Stephen., Wang, Eunice S., Atallah, Ehab, Schiller, Gary J., Martinelli, Giovanni, Neubauer, Andreas, Sierra, Jorge, Montesinos, Pau, Récher, Christian, Yoon, Sung Soo, Hosono, Naoko, Onozawa, Masahiro, Chiba, Shigeru, Kim, Hee Je, Hasabou, Nahla, Lu, Qiaoyang, Tiu, Ramon, Levis, Mark, and Universitat Autònoma de Barcelona. Departament de Medicina

Subjects
Fms-like Tyrosine Kinase 3, Aniline Compounds, Immunology, Cell Biology, Hematology, ACUTE MYELOID-LEUKEMIA, CHEMOTHERAPY, Biochemistry, SORAFENIB, Leukemia, Myeloid, Acute, fms-Like Tyrosine Kinase 3, Recurrence, Pyrazines, Mutation, Humans, FLT3, Follow-Up Studies
Abstract

The phase 3 ADMIRAL (NCT02421939; Study ID: 2215-CL-0301) trial showed superior overall survival in patients with relapsed/refractory FLT3-mutation–positive acute myeloid leukemia (AML) randomized 2:1 to receive the oral FMS-like tyrosine kinase 3 inhibitor gilteritinib vs those randomized to receive salvage chemotherapy (SC). Here we provide a follow-up of the ADMIRAL trial 2 years after the primary analysis to clarify the long-term treatment effects and safety of gilteritinib in these patients with AML. At the time of this analysis, the median survival follow-up was 37.1 months, with deaths in 203 of 247 and 97 of 124 patients in the gilteritinib and SC arms, respectively; 16 gilteritinib-treated patients remained on treatment. The median overall survival for the gilteritinib and SC arms was 9.3 and 5.6 months, respectively (hazard ratio, 0.665; 95% confidence interval [CI], 0.518, 0.853; two-sided P = .0013); 2-year estimated survival rates were 20.6% (95% CI, 15.8, 26.0) and 14.2% (95% CI, 8.3, 21.6). The gilteritinib-arm 2-year cumulative incidence of relapse after composite complete remission was 75.7%, with few relapses occurring after 18 months. Overall, 49 of 247 patients in the gilteritinib arm and 14 of 124 patients in the SC arm were alive for ≥2 years. Twenty-six gilteritinib-treated patients remained alive for ≥2 years without relapse; 18 of these patients underwent transplantation (hematopoietic stem cell transplantation [HSCT]) and 16 restarted gilteritinib as post-HSCT maintenance therapy. The most common adverse events of interest during years 1 and 2 of gilteritinib therapy were increased liver transaminase levels; adverse event incidence decreased in year 2. Thus, continued and post-HSCT gilteritinib maintenance treatment sustained remission with a stable safety profile. These findings confirm that prolonged gilteritinib therapy is safe and is associated with superior survival vs SC. This trial was registered at www.clinicaltrials.gov as #NCT02421939.

Published
2021

337. Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells

Author

Ghelli Luserna Di Rorà, Andrea, primary, Ghetti, Martina, additional, Ledda, Lorenzo, additional, Ferrari, Anna, additional, Bocconcelli, Matteo, additional, Padella, Antonella, additional, Napolitano, Roberta, additional, Fontana, Maria Chiara, additional, Liverani, Chiara, additional, Imbrogno, Enrica, additional, Bochicchio, Maria Teresa, additional, Paganelli, Matteo, additional, Robustelli, Valentina, additional, Sanogo, Seydou, additional, Cerchione, Claudio, additional, Fumagalli, Monica, additional, Rondoni, Michela, additional, Imovilli, Annalisa, additional, Musuraca, Gerardo, additional, Martinelli, Giovanni, additional, and Simonetti, Giorgia, additional

Published
2021
Full Text
View/download PDF

338. Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin

Author

Gottardi, Michele, primary, Simonetti, Giorgia, additional, Sperotto, Alessandra, additional, Nappi, Davide, additional, Ghelli Luserna di Rorà, Andrea, additional, Padella, Antonella, additional, Norata, Marianna, additional, Giannini, Maria Benedetta, additional, Musuraca, Gerardo, additional, Lanza, Francesco, additional, Cerchione, Claudio, additional, and Martinelli, Giovanni, additional

Published
2021
Full Text
View/download PDF

339. Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience

Author

Martino, Massimo, primary, Pitino, Annalisa, additional, Gori, Mercedes, additional, Bruno, Benedetto, additional, Crescimanno, Alessandra, additional, Federico, Vincenzo, additional, Picardi, Alessandra, additional, Tringali, Stefania, additional, Ingrosso, Claudia, additional, Carluccio, Paola, additional, Pastore, Domenico, additional, Musuraca, Gerardo, additional, Paviglianiti, Annalisa, additional, Vacca, Adriana, additional, Serio, Bianca, additional, Storti, Gabriella, additional, Mordini, Nicola, additional, Leotta, Salvatore, additional, Cimminiello, Michele, additional, Prezioso, Lucia, additional, Loteta, Barbara, additional, Ferreri, Anna, additional, Colasante, Fabrizia, additional, Merla, Emanuela, additional, Giaccone, Luisa, additional, Busca, Alessandro, additional, Musso, Maurizio, additional, Scalone, Renato, additional, Di Renzo, Nicola, additional, Marotta, Serena, additional, Mazza, Patrizio, additional, Musto, Pellegrino, additional, Attolico, Immacolata, additional, Selleri, Carmine, additional, Canale, Filippo Antonio, additional, Pugliese, Marta, additional, Tripepi, Giovanni, additional, Porto, Gaetana, additional, Martinelli, Giovanni, additional, Carella, Angelo Michele, additional, and Cerchione, Claudio, additional

Published
2021
Full Text
View/download PDF

340. Poster: ALL-132: Ponatinib Versus Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): PhALLCON Study

Author

Jabbour, Elias, primary, Martinelli, Giovanni, additional, Vignetti, Marco, additional, Kantarjian, Hagop, additional, Gomez-Almaguer, David, additional, Minami, Yosuke, additional, Dombret, Herve, additional, Hennessy, Meliessa, additional, Vorog, Alexander, additional, Wang, Bingxia, additional, and Ribera, Josep-Maria, additional

Published
2021
Full Text
View/download PDF

341. CML-182: SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis

Author

De Santis, Sara, primary, Mancini, Manuela, additional, Monaldi, Cecilia, additional, Bruno, Samantha, additional, Castagnetti, Fausto, additional, Gugliotta, Gabriele, additional, Rosti, Gianantonio, additional, Dan, Elisa, additional, Sinigaglia, Barbara, additional, Iurlo, Alessandra, additional, Abruzzese, Elisabetta, additional, Pregno, Patrizia, additional, Albano, Francesco, additional, Bonifacio, Massimiliano, additional, Tiribelli, Mario, additional, Binotto, Gianni, additional, Galimberti, Sara, additional, Baccarani, Michele, additional, Martinelli, Giovanni, additional, Cavo, Michele, additional, and Soverini, Simona, additional

Published
2021
Full Text
View/download PDF

342. Poster: AML-347: A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-Center Study of FLT3-Mutated AML Patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitor Administration in Real-Life Clinical Practice

Author

Nanni, Jacopo, primary, Audisio, Ernesta, additional, Giannini, Maria Benedetta, additional, Scappini, Barbara, additional, Cambò, Benedetta, additional, Albano, Francesco, additional, Martelli, Maria Paola, additional, Cignetti, Alessandro, additional, Rigolin, Gian Matteo, additional, Fracchiolla, Nicola, additional, Bocchia, Monica, additional, Romani, Claudio, additional, Todisco, Elisabetta, additional, Lunghi, Monia, additional, Mianulli, AnnaMaria, additional, Cilloni, Daniela, additional, Petracci, Elisabetta, additional, Valli, Irene, additional, Zingaretti, Chiara, additional, Cerchione, Claudio, additional, Cangini, Delia, additional, Group, FLAM Collaborative, additional, Papayannidis, Cristina, additional, and Martinelli, Giovanni, additional

Published
2021
Full Text
View/download PDF

343. AML-091: Clinical Outcomes in Patients with Relapsed/Refractory Acute Myeloid Leukemia Treated with Gilteritinib Who Received Prior Midostaurin or Sorafenib

Author

Perl, Alexander E, primary, Altman, Jessica K, additional, Hosono, Naoko, additional, Montesinos, Pau, additional, Podoltsev, Nikolai, additional, Martinelli, Giovanni, additional, Smith, Catherine C, additional, Levis, Mark J, additional, Röllig, Christoph, additional, Groß-Langenhoff, Marco, additional, Hasabou, Nahla, additional, Lu, Qiaoyang, additional, and Tiu, Ramon V, additional

Published
2021
Full Text
View/download PDF

344. ALL-132: Ponatinib Versus Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia: (ALL): PhALLCON Study

Author

Jabbour, Elias, primary, Martinelli, Giovanni, additional, Vignetti, Marco, additional, Kantarjian, Hagop, additional, Gomez-Almaguer, David, additional, Minami, Yosuke, additional, Dombret, Herve, additional, Hennessy, Meliessa, additional, Vorog, Alexander, additional, Wang, Bingxia, additional, and Ribera, Josep-Maria, additional

Published
2021
Full Text
View/download PDF

348. AML-347: A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-Center Study of FLT3-Mutated AML Patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitor Administration in Real-Life Clinical Practice

Author

Nanni, Jacopo, primary, Audisio, Ernesta, additional, Giannini, Maria Benedetta, additional, Scappini, Barbara, additional, Cambò, Benedetta, additional, Albano, Francesco, additional, Martelli, Maria Paola, additional, Cignetti, Alessandro, additional, Rigolin, Gian Matteo, additional, Fracchiolla, Nicola, additional, Bocchia, Monica, additional, Romani, Claudio, additional, Todisco, Elisabetta, additional, Lunghi, Monia, additional, Mianulli, AnnaMaria, additional, Cilloni, Daniela, additional, Petracci, Elisabetta, additional, Valli, Irene, additional, Zingaretti, Chiara, additional, Cerchione, Claudio, additional, Cangini, Delia, additional, Group, FLAM Collaborative, additional, Papayannidis, Cristina, additional, and Martinelli, Giovanni, additional

Published
2021
Full Text
View/download PDF

349. Poster: CML-182: SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis

Author

De Santis, Sara, primary, Mancini, Manuela, additional, Monaldi, Cecilia, additional, Bruno, Samantha, additional, Castagnetti, Fausto, additional, Gugliotta, Gabriele, additional, Rosti, Gianantonio, additional, Dan, Elisa, additional, Sinigaglia, Barbara, additional, Iurlo, Alessandra, additional, Abruzzese, Elisabetta, additional, Pregno, Patrizia, additional, Albano, Francesco, additional, Bonifacio, Massimiliano, additional, Tiribelli, Mario, additional, Binotto, Gianni, additional, Galimberti, Sara, additional, Baccarani, Michele, additional, Martinelli, Giovanni, additional, Cavo, Michele, additional, and Soverini, Simona, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results